LifeMD, Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|
| Revenue | $3.7M | $5.2M | $1.2M | $714.2K | $808.4K | $673.8K |
| Cost of Revenue | $1.0M | $1.9M | $247.8K | $172.9K | $181.3K | $199.9K |
| Gross Profit | $2.7M | $3.3M | $971.1K | $541.3K | $627.1K | $473.9K |
| Gross Margin | 72.4% | 62.9% | 79.7% | 75.8% | 77.6% | 70.3% |
| Operating Expenses | ||||||
| Research & Development | — | — | $23.9K | — | — | — |
| SG&A Expense | $742.0K | $1.0M | $331.4K | $316.4K | $393.4K | $439.2K |
| Operating Income | $-1.2M | $-1.2M | $-262.2K | $-530.9K | $-546.4K | $-540.0K |
| Operating Margin | -33.4% | -22.4% | -21.5% | -74.3% | -67.6% | -80.1% |
| Interest Expense | $100.5K | $48.6K | $37.5K | $4.7K | $3.4K | $3.4K |
| Pretax Income | $-1.4M | $-1.2M | $-172.4K | $-477.7K | $-285.5K | $-462.8K |
| Income Tax Expense | — | — | — | — | — | — |
| Net Income | $-1.2M | $-1.1M | $-62.0K | $-460.5K | $-268.3K | $-445.6K |
| Net Margin | -32.8% | -21.1% | -5.1% | -64.5% | -33.2% | -66.1% |
| EPS (Basic) | $-0.03 | $-0.03 | $0.00 | $-0.02 | $-0.01 | $-0.02 |
| EPS (Diluted) | $-0.03 | $-0.03 | $0.00 | $-0.02 | $-0.01 | $-0.02 |
| Shares Outstanding (Basic) | 41.7M | 33.5M | 30.8M | 30.7M | 30.1M | 28.9M |
| Shares Outstanding (Diluted) | 41.7M | 33.5M | 30.8M | 30.7M | 30.1M | 28.9M |
| Dividends Per Share | — | — | — | — | — | — |